Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020 –2022 patent update

.

Source: Expert Opinion on Therapeutic Patents - September 22, 2023 Category: Drugs & Pharmacology Authors: Carolin JaworskiPetar IlievCarmen W änglerBjörn WänglerBrent PageRalf SchirrmacherJustin J. Baileya Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canadab Faculty of Pharmaceutical Sciences, University of British Colum Source Type: research